Showing results (161-170 of 197) with videos related to

Sort By:
Pageof 20
Inorganic Chemistry|January 17, 2024
Tuning the Softness of the Pendant Arms and the Polyazamacrocyclic Backbone to Chelate the 203Pb/212Pb Theranostic PairMarianna Tosato, Parmissa Randhawa, Luca Lazzari, et al.
Dalton Transactions (Cambridge, England : 2003)|April 7, 2026
Insertion of SnCl2 into the Pd-Cl bond: mechanistic elucidation and antitumor evaluation of trichlorostannyl palladium-NHC allyl complexes in ovarian cancer modelsEleonora Botter, Valentina Lauteri, Alessandro Rubbi, et al.
Natural Product Research|October 26, 2023
Characterisation of the essential oil from Iphiona grantioides and investigation of its antibacterial and antioxidant propertiesShah Iram Niaz, Muhammad Ali, Muhammad Saleem, et al.
Inorganic Chemistry|July 14, 2020
Highly Stable Silver(I) Complexes with Cyclen-Based Ligands Bearing Sulfide Arms: A Step Toward Silver-111 Labeled RadiopharmaceuticalsMarianna Tosato, Mattia Asti, Marco Dalla Tiezza, et al.
Chemistry & Biodiversity|May 5, 2016
Fatty Acid-Derived Pro-Toxicants of the Rat Selective Toxicant NorbormideHans Choi, Daniel Conole, Darcy J Atkinson, et al.
Scientific Reports|February 6, 2019
Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regressionZeynep Kabakci, Simon Käppeli, Claudio Cantù, et al.
Bioorganic Chemistry|March 31, 2019
Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's diseaseGiovanni Ribaudo, Paolo Coghi, Enrico Zanforlin, et al.
Blood|May 2, 2015
Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2AFrancesca Zonta, Mario Angelo Pagano, Livio Trentin, et al.
Chemical Biology & Drug Design|December 1, 2022
Combining computational and experimental evidence on the activity of antimalarial drugs on papain-like protease of SARS-CoV-2: A repurposing studyGiovanni Ribaudo, Xiaoyun Yun, Alberto Ongaro, et al.
Pharmaceutics|August 26, 2022
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson's Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic MiceAndrea Casiraghi, Francesca Longhena, Gaia Faustini, et al.
Pageof 20